Magnetic resonance imaging (MRI)/ultrasound-guided high-intensity focused ultrasound (HIFU) ablates prostate cancer with promising cancer control and minimal impact on sexual or urinary function.

Newswise — Neptune, N.J. – March 2, 2026 – Men with localized prostate cancer have another treatment option available at Hackensack Meridian Jersey Shore University Medical Center (JSUMC) with the ...

A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and treat early prostate cancer while preserving patients' quality of life.

Prostate cancer is one of the most commonly diagnosed cancers in American men, with estimates that 1 in 8 men will be diagnosed with the disease at some point in their life. Once cancer is suspected, ...

MARKHAM, Ontario--(BUSINESS WIRE)--Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro-ultrasound platform to MRI ...

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between scans or start aggressive treatment. Those with certain types of medium-risk ...

A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and experienced less short‑term impact on their daily lives when treated with ...